ISAPP publishes probiotic recommendations for at-risk populations

November 10, 2016. – ISAPP, in collaboration with IPA, publishes paper on use of probiotics in at-risk populations. This paper gives healthcare providers information about using probiotic dietary supplements in at-risk populations. Probiotics should be used in cases where the research shows a benefit for patient populations. But we need to work with industry to be sure that appropriate microbiological quality standards are followed for such products. The paper is published open access in the November/December 2016 issue of the Journal of the American Pharmacists Association. Download here. By Mary Ellen Sanders, PhD, Executive Science Officer ISAPP.